PALIPERIDONE ER TREATMENT AND THE IMPROVEMENT OF SOCIAL AND COGNITIVE FUNCTION IN PATIENTS WITH SCHIZOPHRENICS - A 24-WEEK, SINGLE ARM, OPEN-LABEL STUDY

被引：2

作者：

Shi, Chuan ^{[1
]}

Yu, Xin ^{[1
]}

Kang, Lan ^{[1
]}

Yao, Shuqiao ^{[2
]}

Tang, Xirong ^{[2
]}

Xu, Yifeng ^{[3
]}

Peng, Daihui ^{[3
]}

Shi, Jianguo ^{[4
]}

Lin, Huali ^{[4
]}

Xu, Xiufeng ^{[5
]}

Liu, Fang ^{[5
]}

Zhang, Congpei ^{[6
]}

Wang, Xijin ^{[6
]}

机构：

[1] Peking Univ, Inst Mental Hlth, Beijing, Peoples R China

[2] Cent S Univ, Xiangya Hosp 2, Changsha, Hunan, Peoples R China

[3] Shanghai Jiao Tong Univ, Inst Mental Hlth, Shanghai, Peoples R China

[4] Xian Mental Hlth Ctr, Xian, Shaanxi, Peoples R China

[5] Kunming Med Sch, Affiliated Hosp 1, Kunming, Yunnan, Peoples R China

[6] First Haerbin Psychiat Hosp, Harbin, Heilongjiang, Peoples R China

来源：

SCHIZOPHRENIA RESEARCH | 2014年 / 153卷

关键词：

D O I：

10.1016/S0920-9964(14)70362-7

中图分类号：

R749 [精神病学];

学科分类号：

100205 ;

摘要：

S83

引用

页码：S118 / S118

页数：1

共 50 条

[1] Improvement in social and cognitive functioning associated with paliperidone extended-release treatment in patients with schizophrenia: a 24-week, single arm, open-label study
Shi, Chuan
Yao, Shu Qiao
Xu, Yi Feng
Shi, Jian Guo
Xu, Xiu Feng
Zhang, Cong Pei
Jin, Hua
Yu, Xin
NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2016, 12 : 2095 - 2104
[2] An open-label,prospective study to evaluate social function and overall improvement from paliperidone er in thai schizophrenia patients
Chamsil, C.
Vongpanich, S.
EUROPEAN PSYCHIATRY, 2013, 28
[3] Treatment of active ankylosing spondylitis with abatacept: an open-label, 24-week pilot study
Song, I-H
Heldmann, F.
Rudwaleit, M.
Haibel, H.
Weiss, A.
Braun, J.
Sieper, J.
ANNALS OF THE RHEUMATIC DISEASES, 2011, 70 (06) : 1108 - 1110
[4] Flexible dosing with paliperidone ER in the treatment of patients with acutely exacerbated schizophrenia: results from a single-arm, open-label study
Schmauss, Max
Jukic, Vlado
Siracusano, Alberto
Bidzan, Leszek
Badescu, George M.
Maciulis, Valentinas
Lahaye, Marjolein
Hoeben, Dagmar
Tessier, Christophe
Schreiner, Andreas
CURRENT MEDICAL RESEARCH AND OPINION, 2012, 28 (08) : 1395 - 1404
[5] LURASIDONE IN THE LONG-TERM TREATMENT OF PATIENTS WITH BIPOLAR DISORDER: A 24-WEEK OPEN-LABEL EXTENSION STUDY
Ketter, Terence A.
Sarma, Kaushik
Silva, Robert
Kroger, Hans
Cucchiaro, Josephine
Loebel, Antony
DEPRESSION AND ANXIETY, 2016, 33 (05) : 424 - 434
[6] Efficacy and safety of galantamine in patients with dementia with Lewy bodies: A 24-week open-label study
Edwards, Keith
Royall, Donald
Hershey, Linda
Lichter, David
Hake, Ann
Farlow, Martin
Pasquier, Florence
Johnson, Stewart
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2007, 23 (06) : 401 - 405
[7] An open-label, 24-week pilot study of the methyl donor betaine in Alzheimer disease patients
Knopman, D
Patterson, M
ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 2001, 15 (03): : 162 - 165
[8] Galantamine in the management of dementia with Lewy bodies: A 24-week, open-label study
Edwards, K
Hershey, L
Johnson, S
INTERNATIONAL PSYCHOGERIATRICS, 2003, 15 : 253 - 254
[9] Risperidone in the treatment of mixed state bipolar patients: Results from a 24-week, multicenter, open-label study in Korea
Woo, Young Sup
Bahk, Won-Myong
Jon, Duk-In
Chung, Sang-Keun
Lee, Sang-Yeol
Ahn, Yong Min
Pae, Chi-Un
Cho, Hyun-Sang
Kim, Jeong-Gee
Hwang, Tae-Yeon
Lee, Hong-Seok
Min, Kyung Joon
Lee, Kyung-Uk
Yoon, Bo-Hyun
PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2010, 64 (01) : 28 - 37
[10] Fesoterodine treatment of pediatric patients with neurogenic detrusor overactivity: A 24-week, randomized, open-label, phase 3 study
Kitta, Takeya
Darekar, Amanda
Malhotra, Bimal
Shahin, Mohamed H.
Jones, Philip
Lindsay, Monica
Mallen, Sharon
Nieto, Alejandra
Crook, Tim J.
JOURNAL OF PEDIATRIC UROLOGY, 2023, 19 (02) : 175e1 - 175e10

← 1 2 3 4 5 →